Company

Procyrion, Inc.

Procyrion, Inc. develops the Aortix system, a medical device for acute decompensated heart failure, from Houston.

About

Founded in 2005 and headquartered in Houston, Texas, Procyrion, Inc. develops the Aortix percutaneous mechanical circulatory support device for patients with acute decompensated heart failure, selling it directly to hospitals and clinics. Eric Fain is CEO. The company is at the Series E stage and raised USD 57.671 mn in December 2023, led by Fannin Innovation Studio with returning investor BlueBird Ventures.

3Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in